Patient Information Sheet
Levetiracetam (marketed as Keppra)

PDF Print Version

This is a summary of the most important information about Keppra. For details, talk to your healthcare professional.

What is Keppra used for?

Keppra is a medicine taken with other seizure medicines to treat:

• partial seizures in adults and children 4 years of age and older with epilepsy. 
• myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy.

Special Warning(s) with Keppra: 

Some people taking Keppra can get serious reactions including:

• sleepiness or feeling tired
• weakness
• difficulty coordinating muscles normally, (e.g., abnormal walk)
• aggression, anger, and irritability  
• agitation, anxiety, and other mood changes
• decreased ability to cope with daily life events
• feeling depressed or worsening depression
• thoughts of suicide

Talk to your doctor before stopping Keppra or any other seizure medicine.  Stopping a seizure medicine all at once can cause status epilepticus, a serious problem.

General Precautions with Keppra:

Keppra may cause drowsiness.  Do not drive a car or operate complex machinery until you know how Keppra affects you.

What should I tell my doctor or healthcare provider?

Tell your doctor or healthcare provider if you:

• are pregnant or plan to become pregnant.  Keppra may cause birth defects.  If you are taking Keppra while pregnant, tell your healthcare provider to register you in the Antiepileptic Drug Pregnancy Registry by calling 888-233-2334.
• are nursing or planning to nurse your baby.  Keppra is passed through breast milk to the baby.
• have a history of kidney problems.

Tell your doctor about any other medicines you may be taking, including non-prescription medicines.

What are some possible side effects of Keppra? (This is NOT a complete list of side effects reported with Keppra. Your healthcare provider can discuss with you a more complete list of side effects.)

The most common side effects are:

• drowsiness
• weakness
• dizziness
• infection

For more detailed information about Keppra, ask your healthcare provider.

Link to Keppra's Approved Labeling and Patient Information

Back to Top     Back to Drug Index

PDF requires the free Adobe Acrobat Reader

Date Approved:  November 30, 1999

Date created: March 15, 2001

Date Updated:  August, 2005 and March 22, 2007

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research